Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for adhd
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on adhd or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on adhd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via firstname.lastname@example.org
ADHD (or Attention deficit hyperactivity disorder) is a neurodevelopmental type mental disorder. It is characterised two main categories of two types of behavioural problems:
hyperactivity and impulsiveness
Most people with ADHD have problems that fall into both categories, but it doesn’t have to be the case. If a person just has inattentiveness it is referred to as attention deficit disorder (ADD).
Methylphenidate is a commonly used medication used to treat patients suffering from attention-deficit hyperactivity disorder. Methylphenidate is part of a group of drugs known as stimulants. Central nervous system stimulants help change the amounts of natural substances in the brain. But it is not the only intervention; others include Bupropion, exercise and CBT (Cognitive behavioural therapy).
Extensive ADHD research and case studies have been carried out over numerous years. Trip has unrivalled coverage of the evidence base including systematic reviews, clinical trials, clinical guidelines and case studies.
Studies are ongoing to assess the safety and effectiveness of stimulants used on children with ADHD and intellectual disabilities as well as in other populations and other interventions. Trip also includes ongoing controlled trials and ongoing systematic reviews (via the PROSPERO database).
Attentiondeficithyperactivitydisorder in adults Attentiondeficithyperactivitydisorder in adults - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search Attentiondeficithyperactivitydisorder in adults Last reviewed: February 2019 Last updated: October 2018 Summary A common adult disorder, thought to be persistence of childhood attentiondeficithyperactivitydisorder (ADHD). Prevalence of 2% to 5% in the general (...) in combination with medication. Definition Adult attentiondeficithyperactivitydisorder (ADHD) is a neurodevelopmental disorder presenting with inattentiveness, impulsivity, and hyperactivity, persisting into adulthood. Diagnosis can be made in either adulthood or childhood by 7 years of age (age limit increased in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition [DSM-5] to 12 years). Functional impairment is a criterion for diagnosis. Comorbid disorders are present in more than 75
examination by a physician/medical doctor - Psychological 2016 10. Bupropion for attentiondeficithyperactivitydisorder ( ADHD ) in adults. BACKGROUND: Attentiondeficithyperactivitydisorder ( ADHD ) is a prevalent neurobiological condition, characterised by behavioral and cognitive symptoms such as inattention, impulsivity and/or excessive activity. The syndrome is commonly accompanied by psychiatric comorbidities and is associated with educational and occupational underachievement.Although (...) in improving family and social relationships. On the other hand, it has frequent, sometimes severe, adverse effects. In practice, it is best to avoid guanfacine. The diagnosis of attentiondeficithyperactivitydisorder in children is based on non-specific behavioural symptoms: inattentiveness, hyperactivity and impulsiveness. The disruptive impact on family 2017 17. ADHD in Children and Adolescents ADHD in Children and Adolescents -- Clinical Recommendation Welcome Search Search Specify your search
Association of Digital Media Use With Subsequent Symptoms of Attention-Deficit/HyperactivityDisorder Among Adolescents. Modern digital platforms are easily accessible and intensely stimulating; it is unknown whether frequent use of digital media may be associated with symptoms of attention-deficit/hyperactivitydisorder (ADHD).To determine whether the frequency of using digital media among 15- and 16-year-olds without significant ADHD symptoms is associated with subsequent occurrence of ADHD (...) was defined as many times a day (yes/no) and was summed in a cumulative index (range, 0-14).Self-rated frequency of 18 ADHD symptoms (never/rare, sometimes, often, very often) in the 6 months preceding the survey. The total numbers of 9 inattentive symptoms (range, 0-9) and 9 hyperactive-impulsive symptoms (range, 0-9) that students rated as experiencing often or very often were calculated. Students who had reported experiencing often or very often 6 or more symptoms in either category were classified
Crossing the divide: a longitudinal study of effective treatments for people with autism and attentiondeficithyperactivitydisorder across the lifespan Crossing the divide: a longitudinal study of effective treatments for people with autism and attentiondeficithyperactivitydisorder across the lifespan Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please
Pharmacological treatment for attentiondeficithyperactivitydisorder (ADHD) in children with comorbid tic disorders. This is an update of the original Cochrane Review published in Issue 4, 2011.Attentiondeficithyperactivitydisorder (ADHD) is the most prevalent of the comorbid psychiatric disorders that complicate tic disorders. Medications commonly used to treat ADHD symptoms include stimulants such as methylphenidate and amphetamine; non-stimulants, such as atomoxetine; tricyclic (...) antidepressants; and alpha agonists. Alpha agonists are also used as a treatment for tics. Due to the impact of ADHD symptoms on the child with tic disorder, treatment of ADHD is often of greater priority than the medical management of tics. However, for many decades, clinicians have been reluctant to use stimulants to treat children with ADHD and tics for fear of worsening their tics. OBJECTIVES: To assess the effects of pharmacological treatments for ADHD in children with comorbid tic disorders on symptoms
to a change in prescribing of stimulants to children in BC. Despite concerns, stimulant drug treatment of childhood at- tention-deficit/hyperactivitydisorder (ADHD) has increased worldwide over the last two decades. 1 The optimal manage- ment of this behavioral condition remains unknown and this is reflected in the wide variation of stimulant treatment by country, jurisdiction, income, race and ethnicity. 1,2 Children are particularly vulnerable to harms of long- term drug therapies and there should (...) Letter 2008; 69:1-2. http://ti.ubc.ca/letter69 4. Storebø OJ, Ramstad E, Krogh HB, et al. Methylpheni- date for children and adolescents with attentiondeficit hy- peractivity disorder (ADHD). Cochrane Database of Sys- tematic Reviews 2015, Issue 11. Art. No.: CD009885. DOI: 10.1002/14651858.CD009885.pub2 5. Punja S, Shamseer L, Hartling L, et al. Amphetamines for atten- tion deficithyperactivitydisorder (ADHD) in children and adoles- cents. Cochrane Database of Systematic Reviews 2016, Issue 2
Risk of suicide attempts in adolescents and young adults with attention-deficithyperactivitydisorder: a nationwide longitudinal study Attention-deficithyperactivitydisorder (ADHD) increases the risk of suicidal behaviours through psychiatric comorbidities; however, a significant direct association has not been observed between ADHD and suicide attempts. Aims To evaluate the risk of suicide attempt in adolescents and young adults with ADHD.Using a nationwide, population-based insurance (...) claims database, this longitudinal cohort study enrolled 20 574 adolescents and young adults with ADHD and 61 722 age- and gender-matched controls between 2001 and 2009. Any suicide attempt was identified from enrolment to 31 December 2011. The association between ADHD medications and the likelihood of suicide attempt was assessed.ADHD was an independent risk factor for any suicide attempt (hazard ratio = 3.84, 95% CI = 3.19-4.62) and repeated suicide attempts (hazard ratio = 6.52, 95% CI = 4.46-9.53
Attention-deficit/hyperactivitydisorder medication and seizures Individuals with attention-deficit/hyperactivitydisorder (ADHD) are at increased risk of seizures, but there is uncertainty about whether ADHD medication treatment increases risk among patients with and without preexisting seizures.We followed a sample of 801,838 patients with ADHD who had prescribed drug claims from the Truven Health MarketScan Commercial Claims and Encounters databases to examine whether ADHD medication (...) increases the likelihood of seizures among ADHD patients with and without a history of seizures. First, we assessed overall risk of seizures among patients with ADHD. Second, within-individual concurrent analyses assessed odds of seizure events during months when a patient with ADHD received ADHD medication compared with when the same individual did not, while adjusting for antiepileptic medications. Third, within-individual long-term analyses examined odds of seizure events in relation to the duration
, Ph.D. AHRQ Publication No. 18-EHC005-EF January 2018 ii Key Messages Purpose of Review To update a previous review by comparing strategies to diagnose, treat, and monitor children and adolescents with attentiondeficithyperactivitydisorder (ADHD). Key Messages • Evidence was insufficient on imaging or electroencephalogram to diagnose ADHD in children 7–17 years of age. • Little evidence adds to the 2011 report that found that methylphenidate is effective for children under age 6 with ADHD (...) . Harvard TH Chan School of Public Health Boston, MA Peter Jensen, M.D. Mayo Clinic Rochester, MN viii AttentionDeficitHyperactivityDisorder: Diagnosis and Treatment in Children and Adolescents Structured Abstract Objectives. Attentiondeficithyperactivitydisorder (ADHD) is a common pediatric neurobehavioral disorder often treated in the primary care setting. This systematic review updates and extends two previous Agency for Healthcare Research and Quality (AHRQ) systematic evidence reviews
Psychiatry 2007 ; 164 (6) :942. , 3. Faraone SV, Biederman J, Spencer TJ, Aleardi M . Comparing the efficacy of medications for adhd using meta-analysis . Med Gen Med 2006 ; 8 (4) :4. 4. Hoza B, Gerdes AC, Mrug S, et al. Peer-assessed outcomes in the multimodal treatment study of children with attentiondeficithyperactivitydisorder . J Clin Child Adolesc Psychol 2005 ; 34 (1) :74. , 5. Fabiano GA, Pelham WE, Gnagy EM, et al. The single and combined effects of multiple intensities of behavior (...) modification and methylphenidate for children with attentiondeficithyperactivitydisorder in a classroom setting . School Psychol Rev 2007 ; 36 (2) :195–216. 6. Pliszka S . Practice parameter for the assessement and treatment of children and adolescents with attention-deficit/hyperactivitydisorder . J Am Acad Child Adolesc Psychiatry 2017 ; 46 (7) :894–921. , 7. Antshel KM, Olszewski AK . Cognitive behavioral therapy for adolescents with adhd . Child Adolesc Psychiatr Clin N Am 2014 ; 23 (4) :825–42
of Educational Sciences and Psychology, University of Mohaghegh Ardabili, Ardabil, Iran., Ardabil 2- Department of Psychology, Faculty of Educational Sciences and Psychology, University of Mohaghegh Ardabili, Ardabil, Iran. , email@example.com Abstract: (2884 Views) Objective: The aim of this meta-analysis was to determine the effectiveness of neurofeedback treatments in adults with AttentionDeficit/ HyperactivityDisorder (ADHD). Methods: A total of 9 studies were selected, and meta-analysis was done (...) =0.0384), for hyperactivity/impulsivity is ES=0.510 (P=0.001), and for total ADHD is ES=0.630 (P=0.0038). Conclusion: Based on the results of this meta-analysis, neurofeedback treatment was found to have a large effect in reducing ADHD symptoms in adults with attentiondeficit/ hyperactivitydisorder. Keywords: , , , (3961 Downloads) | | (2136 Views) Type of Study: | Subject: Received: 2017/09/13 | Accepted: 2018/01/5 | Published: 2018/04/1 * Corresponding Author Address: Department of Psychology
Computerized cognitive training in children and adolescents with attentiondeficit/hyperactivitydisorder as add-on treatment to stimulants: feasibility study and protocol description. Cognitive training has received increasing attention as a non-pharmacological approach for the treatment of attentiondeficit/hyperactivitydisorder (ADHD) in children and adolescents. Few studies have assessed cognitive training as add-on treatment to medication in randomized placebo controlled trials (...) . The purpose of this preliminary study was to explore the feasibility of implementing a computerized cognitive training program for ADHD in our environment, describe its main characteristics and potential efficacy in a small pilot study.Six ADHD patients aged 10-12-years old receiving stimulants and presenting residual symptoms were enrolled in a randomized clinical trial to either a standard cognitive training program or a controlled placebo condition for 12 weeks. The primary outcome was core ADHD
Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling? Among US adults, utilization of pharmacotherapy for attention-deficithyperactivitydisorder (ADHD) has increased more than ninefold since 1995-1996. Potential contraindications to ADHD pharmacotherapy include serious cardiovascular disease (CVD) and, for stimulants, addictions and bipolar disorder (BPD).To assess the prevalence (...) of potential contraindications among adults treated with ADHD pharmacotherapy.A retrospective cohort analysis was performed using the Truven Health MarketScan® database. Subjects filled ≥ 1 prescription for atomoxetine or ≥ 1 stimulant in 2014-2015, were aged 18-64 years, commercially insured throughout observation, and diagnosed with ADHD on two or more medical claims. Diagnoses and medical procedures were measured in the 12 months prior to pharmacotherapy initiation. Metrics included serious CVD
Lisdexamfetamine Targets Amygdala Mechanisms That Bias Cognitive Control in Attention-Deficit/HyperactivityDisorder. Prefrontal-limbic circuits that form the neural architecture for emotion to influence behavior have been implicated in the pathophysiology of attention-deficit/hyperactivitydisorder (ADHD) and represent a potentially important target of medication treatment that has not been substantively evaluated. This study tested the effect of the psychostimulant prodrug lisdexamfetamine (...) dimesylate on amygdala activation and connectivity during the emotional bias of response execution and inhibition.Twenty-five adults with ADHD were scanned twice with event-related functional magnetic resonance imaging while performing an emotional go/no-go task after 3 to 4 weeks of lisdexamfetamine treatment and 3 weeks off medication in a randomized, counterbalanced, hybrid crossover design. Drug, trial type, and face emotion (happy, sad, or neutral) were included as within-subjects factors
treatment reduces the risk of motor vehicle crashes among men and women with ADHD Aida Bikic 1 , Søren Dalsgaard 2 Statistics from Altmetric.com COMMENTARY ON: Chang Z, Quinn PD, Hur K, Gibbons RD, Sjölander A, Larsson H & D’Onofrio. Association between medication use for attention-deficit/hyperactivitydisorder and risk of motor vehicle crashes. JAMA Psychiatry 2017;74(6):597–603. What is already known on this topic Attention-deficit/hyperactivitydisorder (ADHD) is a neurodevelopmental disorder (...) with core symptoms of inattention, hyperactivity and impulsivity,; traits that may increase the risk of injuries and motor vehicle crashes (MVCs). Injuries in early childhood predict later ADHD, 1 a diagnosis that is associated with a twofold increased risk of premature death, with accidents being the most common cause of death. 2 ADHD is commonly treated with pharmacotherapy that successfully targets most of the impairing core symptoms. 3 In children with ADHD, pharmacological treatment also reduces